Through the services provided by Haemonitics, proper blood management is put in place in blood banks to hospitals. Their product portfolio also ensures that only those patients, who are really qualified for blood transfusion will be receiving blood at the right time, with the right blood and at the right dosage. The company is on top of the blood supply chain and maintains its position through its comprehensive product portfolio, which includes blood management solutions, information management and devices that are marketed for blood-related use.
From a small venture, the business is now considered as the world’s leader in blood management solutions. The suite of devices and consumables that they offer to the blood market has changed the way the world collects, processes and uses blood in the surgical suite. With its expertise and cutting edge technology, the company is poised to change the process of blood management.
There are two broad product categories that Haemonitics markets: Donor Products and Patient Products. Their Donor Products offerings include those devices that support pathogen activation and bacterial detection in blood that is collected, equipment that automates the donation and processing of blood and products that are used to test blood hematocrit. Their Patient Products are marketed to the surgical suite. These products include surgical field blood suction systems; blood and patient warming systems and devices for surgical blood salvage.
Holding offices in about 16 countries, the business is focused on growing its business in its three key markets: Asia, Europe and the Americas. Haemonitics is a publicly held company on the New York Stock Exchange.